Drugs / CD0271/CD1579
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03034460 | Apr → Nov 2016 | acne | Galderma R&D | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD0271/CD1579 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03034460 ↗ |
| Route | Topical | “500 µL on half-face” NCT03034460 ↗ |